AU6686700A - Treatment of urinary incontinence - Google Patents

Treatment of urinary incontinence

Info

Publication number
AU6686700A
AU6686700A AU66867/00A AU6686700A AU6686700A AU 6686700 A AU6686700 A AU 6686700A AU 66867/00 A AU66867/00 A AU 66867/00A AU 6686700 A AU6686700 A AU 6686700A AU 6686700 A AU6686700 A AU 6686700A
Authority
AU
Australia
Prior art keywords
treatment
urinary incontinence
incontinence
urinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66867/00A
Other languages
English (en)
Inventor
Sandeep Gupta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU6686700A publication Critical patent/AU6686700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU66867/00A 1999-08-23 2000-08-23 Treatment of urinary incontinence Abandoned AU6686700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199901157 1999-08-23
DKPA199901157 1999-08-23
PCT/DK2000/000468 WO2001013918A1 (en) 1999-08-23 2000-08-23 Treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
AU6686700A true AU6686700A (en) 2001-03-19

Family

ID=8101650

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66867/00A Abandoned AU6686700A (en) 1999-08-23 2000-08-23 Treatment of urinary incontinence

Country Status (4)

Country Link
AR (1) AR025353A1 (es)
AU (1) AU6686700A (es)
CO (1) CO5440228A1 (es)
WO (1) WO2001013918A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL208138B1 (pl) * 2001-07-10 2011-03-31 Astellas Pharma Inc Zastosowanie kompozycji farmaceutycznej
FR2910814B1 (fr) * 2006-12-28 2011-06-17 Pf Medicament Utilisation du 10-°(r3)-1-azabicyclo°2.2.2!oct-3-ylmethyl!-10h- phenothiazine pour la preparation d'un medicament exercant une inhibition selective des recepteurs muscariniques m1,2,3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
EP0863141B1 (en) * 1995-10-13 2001-09-12 Banyu Pharmaceutical Co., Ltd. Substituted heteroaromatic derivatives
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor

Also Published As

Publication number Publication date
WO2001013918A1 (en) 2001-03-01
AR025353A1 (es) 2002-11-20
CO5440228A1 (es) 2004-09-30

Similar Documents

Publication Publication Date Title
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
AU6422400A (en) Disposable urinary aid
AU3378800A (en) Male urinary incontinence device
EP1014957A4 (en) URINARY INCONTINENCE THERAPY
AU7360700A (en) Methods and compositions for preventing and treating urinary tract disorders
AU2003214273A1 (en) Improved system for the treatment of stress urinary incontinence
HUP0200738A3 (en) Method of the treatment of incontinence
AUPQ968700A0 (en) Treatment of urinary incontinence
AU3896900A (en) Treatment of pain
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU3760900A (en) Treatment of menstrual function
HUP0104514A2 (en) The use of aril-substituted cyclobutylalkylamines for treating urinary incontinence
AU1196601A (en) Methods of diagnosing and treating urinary incontinence
AU6686700A (en) Treatment of urinary incontinence
AU2002242705A1 (en) Utilization of buprenorphine in urinary incontinence therapy
AU5552400A (en) Treatment of cancer
AUPQ367699A0 (en) Treatment of cancer
AU1405001A (en) Treatment of diseases
AU1166000A (en) 1-aminoethylquinoline derivatives for treating urinary incontinence
AU3971400A (en) 1-amino ethylindole derivatives for the treatment of urinary incontinence
AU6619398A (en) Treatment of urinary incontinence
AU7551800A (en) Female urinary incontinence catheter
AU2002215943A1 (en) Novel M-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence
IL141264A0 (en) Treatment of fecal incontinence

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase